Unresponsive Therapy: Definition, Causes, and Clinical Approach

Unresponsive therapy (or treatment failure/refractoriness) refers to a clinical situation where a correctly administered, evidence-based treatment fails to produce the expected therapeutic effect in a patient who adheres to the regimen.

Common Causes

• Diagnostic Error: Wrong diagnosis (e.g., treating viral pneumonia as bacterial; misclassifying seizure type).
• Pharmacokinetic Factors: Poor absorption, rapid metabolism, drug interactions (inducers), non-adherence (unrecognized).
• Pharmacodynamic Resistance: Genetic polymorphisms, receptor mutations, pathway redundancy (e.g., antibiotic resistance, tumor heterogeneity).
• Disease Progression: Underlying condition advances beyond treatment capacity.
• Comorbidities/Concurrent Meds: Counteract treatment effect.
• Placebo/Nocebo Effects: Psychological modulation of response.

Systematic Approach

1. Verify diagnosis (review data, consider second opinion).
2. Confirm adherence (pill counts, pharmacy records, drug levels).
3. Assess adequacy: dose, duration, route, formulation.
4. Evaluate interactions, organ function (renal/hepatic).
5. Consider alternative diagnoses or resistant phenotypes.
6. Escalate: switch class, add agent, refer specialist, clinical trial.

Document reasoning; involve patient in shared decision-making. "Unresponsive" is a call to re-evaluate, not a label for the patient.